International Journal of Preventive Medicine · 2015 · 13 citations · 28 references
MedicineNutritionOncologyBone MetabolismChemotherapyMineral MetabolismBone HealthBone Metabolism DisordersRadiation Exposure In ChildhoodVitamin DVitamin D DeficiencyVitamin D MetabolismBone Health DisordersLow Bone Mineral DensityPediatric Vitamin D DeficiencySerum 25-Hydroxyvitamin D StatusSerum Calcium MeasurementVitamin D BiomarkersVitamin D Effects On BoneVitamin D Insufficiency
BACKGROUND: Low vitamin D and diminished bone minerals with the potential for fractures are one of the nonapparent late effects of acute lymphoblastic leukemia (ALL). Chemotherapy and radiation were known as two important risk factors. We evaluated these late effects in ALL survivors who were treated with chemotherapy or chemo plus cranial radiation therapy. METHODS: In a case-control study, 33 of ALL survivors who were treated with chemotherapy (Group A), and 33 subjects who were treated with chemoplus cranial radiation (Group B) were compared against 33 matched age, sex, and pubertal stage of their healthy siblings (Group C). Standard anthropometric data were collected as well as Tanner staging for puberty, number of fractures since treatment, serum calcium (Ca), phosphorus (P), magnesium (Mg), alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D (25(OH) D). The independent t-test, one-way ANOVA, Chi-square test, and Tukey's test were used to analyze the data. RESULTS: The findings indicated that the mean serum levels of 25(OH) D in ALL survivors (i.e. Groups A and B) with age mean score of 11.2 years and 12.3 years, average treatment length: 3.25 years and average time after treatment completion: 4 years, was lower compared to the controls group (12.94 ± 6.69, 14.6 ± 8.1, 20.16 ± 10.83, respectively, P < 0.001) but no significant difference was observed between Group A and B in this regard (P > 0.05). Other clinical and laboratory parameters had no significant differences between the survivors and control. Vitamin D deficiency (<20 ng/ml) was observed in 27% of group A and 24% of group B and vitamin D insufficiency (20-30 ng/ml) in 72.7% and 69.6% survivors of Group A and B and 48.5% of controls group (P = 0.003). CONCLUSIONS: ALL treatment is associated with the increase in prevalence of vitamin D insufficiency in the childhood ALL survivors and since the low vitamin D level potentially increases the risk of low bone density, subsequent malignancies, and cardiovascular disease in the survivors, close follow-up of such patients are highly recommended to prevent the stated complications.
28
Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004
Juhi Kumar, Paul Muntner, Frederick J. Kaskel et al. · PEDIATRICS · 2009 · 620 citations · Full text
Medicine, Child Health, Pediatrics +15
Bony Morbidity in Children Treated for Acute Lymphoblastic Leukemia
Adam J. Strauss, Joyce T. Su, Virginia Dalton et al. · Journal of Clinical Oncology · 2001 · 252 citations
Medicine, Oncology, Pediatrics +11